Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atherosclerotic nephropathy.

J E Scoble1

  • 1Guy's Hospital, London, United Kingdom. j.scoble@umds.co.uk

Kidney International. Supplement
|July 21, 1999
PubMed
Summary
This summary is machine-generated.

Atherosclerotic nephropathy, linked to aortic atherosclerosis and renal artery stenosis, contributes significantly to end-stage renal failure, especially in older adults. This condition involves various factors beyond ischemia, including atheroembolic disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laudable pus - lardaceous kidneys.

American journal of nephrology·2002
Same author

A late complication of spousal kidney donation.

Clinical nephrology·2002
Same author

Nephrotic syndrome: more than just oedema.

International journal of clinical practice·2002
Same author

Effect of chronic renal failure on mortality rate following arterial reconstruction.

The British journal of surgery·2002
Same author

Which patients benefit from angioplasty?

Advances in nephrology from the Necker Hospital·2001
Same author

'Flash pulmonary oedema'--a diagnosis for both the cardiologist and the nephrologist?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pathology

Background:

  • Lipid moieties impact kidney function directly and indirectly.
  • Aortic atherosclerosis and renal artery stenosis are linked to end-stage renal failure.
  • Atherosclerotic nephropathy is an emerging disease entity.

Purpose of the Study:

  • To examine evidence for atherosclerotic nephropathy.
  • To review the incidence of atherosclerotic renal artery stenosis in end-stage renal failure.
  • To identify associated features of atherosclerotic renal stenosis.

Main Methods:

  • Review of published data on the incidence of atherosclerotic renal artery stenosis.
  • Analysis of associated features of atherosclerotic renal stenosis.
  • Examination of data on renal function and morphology in relation to stenosis.

Related Experiment Videos

Main Results:

  • Atherosclerotic renal artery stenosis causes 14-25% of end-stage renal failure in older patients.
  • Proteinuria is common in patients with atherosclerotic renal artery stenosis.
  • Renal length may decrease with significant stenosis, and contralateral renal function can also be impaired.

Conclusions:

  • Multiple processes contribute to renal dysfunction in atherosclerotic aortic disease.
  • Atheroembolic disease is a significant factor, alongside ischemia.
  • The term "atherosclerotic nephropathy" is proposed for this condition.